The San Antonio Business Journal will host the Impact Awards on Nov. 4, 2026, celebrating the Impact of people and businesses ...
Dubbed a patient-in-residence at Bakar Bio Labs, where he was embedded earlier this year with gene therapy startup NV ...
Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and ...
The Embolden trial builds on positive interim data from the Phase 1/2 trial of NGN-401, which demonstrated multidomain, durable gains with continued developmental milestone acquisitions as of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results